Remifentanil and cyclooxygenase inhibitors interactions in the minimum alveolar concentration of sevoflurane in the rat

Benito, J.; Aguado, D.; Abreu, M. B.; García-Fernández, J.; Gómez de Segura, I. A.
December 2010
BJA: The British Journal of Anaesthesia;Dec2010, Vol. 105 Issue 6, p810
Academic Journal
Background Intraoperative opioids reduce anaesthetic requirements and thus limit the side-effects derived from high doses of the latter. Cyclooxygenase (COX) inhibitors can also be given but it remains unclear whether they further reduce the anaesthetic requirements. Our aim was to determine whether COX inhibitors potentiate the effect of remifentanil on the minimum alveolar concentration (MAC) of sevoflurane anaesthetized rats. Methods Male Wistar rats received remifentanil under sevoflurane anaesthesia, and the MAC was determined before and at two time intervals after, separated by 1.5 h. Rats were randomly allocated to receive paracetamol, metamizole, ketoprofen, or parecoxib just before one of the two studied time intervals. The MAC was determined from alveolar gas samples at the time of tail clamp. Data were analysed with an analysis of variance for repeated measures. Results Paracetamol potentiated the MAC reduction produced by remifentanil in rats (P=0.002), whereas metamizole, ketoprofen, and parecoxib failed to produce such an effect. Furthermore, paracetamol and remifentanil produced a maximum degree of MAC reduction [35 (10)%] even when a tolerance effect to remifentanil was observed in animals given remifentanil alone (P<0.001). A tolerance to remifentanil was not observed when metamizole, ketoprofen, or parecoxib was given once the opioid infusion has been started (P>0.05). Conclusions COX inhibitors differentially potentiate the analgesic effect produced by remifentanil on the sevoflurane MAC, and paracetamol was the most effective drug. However, since all COX inhibitors prevented a tolerance effect to opioids once it was established, intraoperative rather than preoperative administration of these drugs is suggested.


Related Articles

  • Effects of Nabumetone and Dipyrone on Experimentally Induced Gastric Ulcers in Rats. Yıldırım, Engin; Sağıroğlu, Oya; Kılıç, Fatma; Erol, Kevser // Inflammation;Apr2013, Vol. 36 Issue 2, p476 

    Nabumetone and dipyrone are non-acidic, nonsteroidal anti-inflammatory drugs. Both of them are known to have weak inhibitory effects of cyclooxygenases. Gastric side effects represent the most common adverse drug effects of the widely used nonsteroidal anti-inflammatory drugs. The gastric...

  • The Adverse Effect of Selective Cyclooxygenase-2 Inhibitor on Random Skin Flap Survival in Rats. Ren, Haiyong; Lin, Dingsheng; Mou, Zhenyu; Dong, Pu // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Background:Cyclooxygenase-2(COX-2) inhibitors provide desired analgesic effects after injury or surgery, but evidences suggested they also attenuate wound healing. The study is to investigate the effect of COX-2 inhibitor on random skin flap survival. Methods:The McFarlane flap model was...

  • Cerivastatin induces type-I fiber-, not type-II fiber-, predominant muscular toxicity in the young male F344 rats. Obayashi, Hisakuni; Nezu, Yoshikazu; Yokota, Hatsue; Kiyosawa, Naoki; Mori, Kazuhiko; Maeda, Naoyuki; Tani, Yoshiro; Manabe, Sunao; Sanbuissho, Atsushi // Journal of Toxicological Sciences;Aug2011, Vol. 36 Issue 4, p445 

    3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are associated with adverse skeletal muscle toxicity, but the underlying mechanism remains unclear. To investigate the pathological mechanism of statin-induced myotoxicity, cerivastatin (20 ppm; corresponding to 2 mg/kg/day)...

  • Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. N. Dietis; R. Guerrini; G. Calo; S. Salvadori; D. J. Rowbotham; D. G. Lambert // BJA: The British Journal of Anaesthesia;Jul2009, Vol. 103 Issue 1, p38 

    Opioid receptors are currently classified as µ (mu: mOP), δ (delta: dOP), κ (kappa: kOP) with a fourth related non-classical opioid receptor for nociceptin/orphainin FQ, NOP. Morphine is the current gold standard analgesic acting at MOP receptors but produces a range of...

  • Phosphoproteomics and Bioinformatics Analyses of Spinal Cord Proteins in Rats with Morphine Tolerance. Liaw, Wen-Jinn; Tsao, Cheng-Ming; Huang, Go-Shine; Wu, Chin-Chen; Ho, Shung-Tai; Wang, Jhi-Joung; Tao, Yuan-Xiang; Shui, Hao-Ai // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Introduction: Morphine is the most effective pain-relieving drug, but it can cause unwanted side effects. Direct neuraxial administration of morphine to spinal cord not only can provide effective, reliable pain relief but also can prevent the development of supraspinal side effects. However,...

  • Methylnaltrexone bromide/opioid analgesics.  // Reactions Weekly;11/3/2012, Issue 1426, p32 

    The article describes the cases of four older patients who developed narcotic bowel syndrome while receiving opioid analgesics.

  • Painkiller alert.  // HealthFacts;Jan98, Vol. 23 Issue 1, p3 

    Cites a letter to the editor of the `Journal of the American Medical Association,' dated November 26, 1997 by Laura H. Kahn and colleagues concerning adverse drug events reported to the US Food and Drug Administration as of July 31, 1996 in the use of the synthetic opioid Ultram for the...

  • Further Characterization of a Novel Tetrapeptide with an Analgesic Action in the Central and Peripheral Nervous System in Rats. Skubatz, Hanna; Klatt, Brian // International Journal of Peptide Research & Therapeutics;Mar2012, Vol. 18 Issue 1, p41 

    The novel tetrapeptide FLPS has been previously shown to induce antinociception in a model of post-incisional pain in the rat. It has been demonstrated in membrane preparations of rat brain that 10 μM tetrapeptide did not compete with [H]naloxone for its binding site on the opioid receptors...

  • The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis. Rundfeldt, Chris; Socała, Katarzyna; Wlaź, Piotr // Journal of Neural Transmission;Nov2010, Vol. 117 Issue 11, p1319 

    Tofisopam is a member of the 2,3-benzodiazepine compound family which is marketed for the treatment of anxiety in some European countries. In contrast to classical 1,4-benzodiazepines, the compound does not bind to the benzodiazepine binding site of the γ-aminobutyric acid receptor and its...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics